Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 9—September 2016
Correction

Correction: Vol. 18, No. 2

Mira Meriluoto, Lea Hedman, Laura Tanner, Ville Simell, Marjaana Mäkinen, Satu Simell, Juha Mykkänen, Jan Korpelainen, Olli Ruuskanen, Jorma Ilonen, Mikael Knip, Olli Simell, Klaus Hedman, and Maria Söderlund-VenermoComments to Author 
Author affiliations: University of Helsinki, Helsinki, Finland (M. Meriluoto, L. Hedman, M. Knip, K. Hedman, M. Söderlund-Venermo); Helsinki University Central Hospital, Helsinki (L. Hedman, M. Knip, K. Hedman); University of Turku, Turku, Finland (L. Tanner, V. Simell, M. Mäkinen, S. Simell, J. Mykkänen, J. Korpelainen, O. Ruuskanen, J. Ilonen, O. Simell); University of Eastern Finland, Kuopio, Finland (J. Ilonen); Tampere University Hospital, Tampere, Finland (M. Knip); Folkhälsan Research Center, Helsinki (M. Knip)

Cite This Article

To the Editor: In our earlier assessment of the etiologic role of human bocavirus 1 (HBoV1) among 109 constitutionally healthy children, seroconversion measured by a standard IgG enzyme immunoassay (EIA) was the prime marker of acute infection, and signs and symptoms during sampling intervals were interpreted from hand-written questionnaires and study nurse notes (1). In that study, we found that acute HBoV1 infection was associated with upper respiratory tract illness (URTI) and acute otitis media. However, after discovery of 3 new human bocaviruses (HBoV2–4), we used a competitive second-generation IgG EIA to differentiate between type-specific and cross-reacting IgG responses and reassessed the etiologic associations of each virus in the same pediatric cohort. We found only a weak correlation of HBoV1 infection with acute otitis media and no correlation with URTI (2).

There are 2 reasons for this discrepancy. First, the competitive second-generation EIA generated a different set of HBoV1-infected children. A total of 27 children initially interpreted as having HBoV1 seroconversions had, on reassessment, HBoV2 or HBoV3 seroconversions (2). Second, after improved reevaluation of clinical symptoms of the entire replenished cohort by 3 of the co-authors, we found that URTI symptoms of 38 children were classified differently. Despite tight sampling, intervals of 3 and 6 months might still have been too long for clinical assessment for young children with numerous respiratory infections per year. The authors regret any inconvenience to readers.

Top

References

  1. Meriluoto  M, Hedman  L, Tanner  L, Simell  V, Mäkinen  M, Simell  S, Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis. 2012;18:26471. DOIPubMedGoogle Scholar
  2. Kantola  K, Hedman  L, Tanner  L, Simell  V, Mäkinen  M, Partanen  J, B-cell responses to human bocaviruses 1–4: new insights from a childhood follow-up study. PLoS One. 2015;10:e0139096. DOIPubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid2209.c12209

Table of Contents – Volume 22, Number 9—September 2016

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Maria Söderlund-Venermo, Department of Virology, University of Helsinki, PO Box 21, Haartmaninkatu 3, Helsinki 00014, Finland

Send To

10000 character(s) remaining.

Top

Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external